108 related articles for article (PubMed ID: 11256928)
1. Disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid disease.
Subhash C; Agarwal AK; Rewari BB; Sangla KS; Vijay A
J Assoc Physicians India; 1995 Mar; 43(3):232-3. PubMed ID: 11256928
[No Abstract] [Full Text] [Related]
2. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
Ranganath VK; Furst DE
Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
Ranganath VK; Furst DE
Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
[TBL] [Abstract][Full Text] [Related]
4. DMARDS and infections in rheumatoid arthritis.
Caporali R; Caprioli M; Bobbio-Pallavicini F; Montecucco C
Autoimmun Rev; 2008 Dec; 8(2):139-43. PubMed ID: 19014871
[TBL] [Abstract][Full Text] [Related]
5. [Disease modifying anti-rheumatic drugs (DMARDs): an overview].
Kawabata D; Mimori T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():489-92. PubMed ID: 15799404
[No Abstract] [Full Text] [Related]
6. Pharmacogenomics in rheumatoid arthritis.
Ranganathan P
Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
[TBL] [Abstract][Full Text] [Related]
7. Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007.
Rantalaiho V; Kautiainen H; Virta L; Korpela M; Möttönen T; Puolakka K
Scand J Rheumatol; 2011 Jan; 40(1):16-21. PubMed ID: 20726683
[TBL] [Abstract][Full Text] [Related]
8. [Attaching importance to the traditional disease modifying antirheumatic drugs].
Yang XY
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1873-4. PubMed ID: 19039995
[No Abstract] [Full Text] [Related]
9. Are biologics more effective than classical disease-modifying antirheumatic drugs?
Nurmohamed MT; Dijkmans BA
Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
[TBL] [Abstract][Full Text] [Related]
10. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Agarwal S; Zaman T; Handa R
Singapore Med J; 2009 Jul; 50(7):686-92. PubMed ID: 19644623
[TBL] [Abstract][Full Text] [Related]
11. Drug management of early rheumatoid arthritis - 2008.
Sokka T; Mäkinen H
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.
Kapral T; Stamm T; Machold KP; Montag K; Smolen JS; Aletaha D
Arthritis Res Ther; 2006; 8(2):R46. PubMed ID: 16507172
[TBL] [Abstract][Full Text] [Related]
13. Disease-modifying antirheumatic drugs.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
[No Abstract] [Full Text] [Related]
14. [New therapeutic approaches. 2. New anti-rheumatic drugs: with special reference to methotrexate].
Eguchi K
Nihon Naika Gakkai Zasshi; 2000 Oct; 89(10):2138-45. PubMed ID: 11215129
[No Abstract] [Full Text] [Related]
15. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
Yen JH
Biomed Pharmacother; 2006 Dec; 60(10):688-92. PubMed ID: 17049202
[TBL] [Abstract][Full Text] [Related]
16. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of disease-modifying anti-rheumatic drugs.
Tanaka E; Taniguchi A; Urano W; Yamanaka H; Kamatani N
Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):233-47. PubMed ID: 15121042
[TBL] [Abstract][Full Text] [Related]
18. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
[TBL] [Abstract][Full Text] [Related]
19. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
Goodemote P; Jamieson B; Hoffman R
J Fam Pract; 2007 Nov; 56(11):933-4, 937. PubMed ID: 17976342
[No Abstract] [Full Text] [Related]
20. What's new in rheumatoid arthritis? An evidenced based review.
Ostor AJ; McColl GJ
Aust Fam Physician; 2001 Apr; 30(4):314-20. PubMed ID: 11355216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
